Monday - February 23, 2026
Statement from Breakthrough T1D on FTC Action and Congressional PBM Reforms Impacting Insulin Affordability
February 10, 2026
NEW YORK, Feb. 10 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:

* * *

Statement from Breakthrough T1D on FTC Action and Congressional PBM Reforms Impacting Insulin Affordability

*

Breakthrough T1D applauds recent action by the Federal Trade Commission (FTC) to finalize a settlement with Express Scripts, one of the nation's largest pharmacy benefit managers . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products